These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 17175117)
21. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells. Duan J; Chen Z; Liu P; Zhang Z; Tong T Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605 [TBL] [Abstract][Full Text] [Related]
22. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells. Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801 [TBL] [Abstract][Full Text] [Related]
23. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition. Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512 [TBL] [Abstract][Full Text] [Related]
24. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Cerone MA; Londoño-Vallejo JA; Autexier C Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163 [TBL] [Abstract][Full Text] [Related]
25. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner. Tamakawa RA; Fleisig HB; Wong JM Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664 [TBL] [Abstract][Full Text] [Related]
26. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725 [TBL] [Abstract][Full Text] [Related]
27. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells. Gurung RL; Lim SN; Low GK; Hande MP J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559 [TBL] [Abstract][Full Text] [Related]
28. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines. Parsch D; Brassat U; Brümmendorf TH; Fellenberg J Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350 [TBL] [Abstract][Full Text] [Related]
29. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy. Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339 [TBL] [Abstract][Full Text] [Related]
30. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53. Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373 [TBL] [Abstract][Full Text] [Related]
31. Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells. McCaul JA; Gordon KE; Minty F; Fleming J; Parkinson EK Oral Oncol; 2008 Mar; 44(3):261-9. PubMed ID: 17475542 [TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887 [TBL] [Abstract][Full Text] [Related]
33. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells. Koziel JE; Herbert BS Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551 [TBL] [Abstract][Full Text] [Related]
34. Radiation sensitivity increases with proliferation-associated telomere dysfunction in nontransformed human epithelial cells. Soler D; Pampalona J; Tusell L; Genescà A Aging Cell; 2009 Aug; 8(4):414-25. PubMed ID: 19473118 [TBL] [Abstract][Full Text] [Related]
35. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line. Pantic M; Zimmermann S; Waller CF; Martens UM Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713 [TBL] [Abstract][Full Text] [Related]
36. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794 [TBL] [Abstract][Full Text] [Related]
37. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR. Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384 [TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibitors in cancer therapy: current status and future directions. Incles CM; Schultes CM; Neidle S Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225 [TBL] [Abstract][Full Text] [Related]
39. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs]. Raymond E; Faivre S; Dieras V; Von Hoff D Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365 [TBL] [Abstract][Full Text] [Related]
40. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells. Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]